Literature DB >> 12955011

Growth hormone deficiency (GHD) from birth to 2 years of age: diagnostic specifics of GHD during the early phase of life.

Amanda L Ogilvy-Stuart1.   

Abstract

The first 2 years of life represent a transition period when growth changes from predominantly growth hormone (GH) independent to GH dependent. In the fetus, growth is influenced by genetic and environmental factors in addition to nutrition and growth factors including insulin. In infancy, nutrition remains an important determinant of growth. GH levels are high in mid-gestation and at birth, then fall sharply for the first few weeks and more slowly over the next few months reaching pre-pubertal levels by around the age of 6 months. GH deficiency (GHD) may present at birth with hypoglycaemia, micropenis or prolonged conjugated hyperbilirubinaemia. Although length at birth is usually within the normal centile ranges, post-natal growth failure can begin early and be profound. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955011     DOI: 10.1159/000071219

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  10 in total

1.  Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth.

Authors:  Mark P Rogan; Leah R Reznikov; Alejandro A Pezzulo; Nicholas D Gansemer; Melissa Samuel; Randall S Prather; Joseph Zabner; Douglas C Fredericks; Paul B McCray; Michael J Welsh; David A Stoltz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

2.  Adding Glucagon-Stimulated GH Testing to the Diagnostic Fast Increases the Detection of GH-Sufficient Children.

Authors:  Colin P Hawkes; Adda Grimberg; Vivian E Dzata; Diva D De Leon
Journal:  Horm Res Paediatr       Date:  2016-03-17       Impact factor: 2.852

3.  Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis.

Authors:  Yaling Yi; Andrew W Norris; Kai Wang; Xingshen Sun; Aliye Uc; Antoinette Moran; John F Engelhardt; Katie Larson Ode
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 21.405

Review 4.  Measuring growth hormone and insulin-like growth factor-I in infants: what is normal?

Authors:  Colin Patrick Hawkes; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2013-12

Review 5.  The molecular basis of hypopituitarism.

Authors:  Christopher J Romero; Suzana Nesi-França; Sally Radovick
Journal:  Trends Endocrinol Metab       Date:  2009-10-23       Impact factor: 12.015

6.  An essential role for IGF2 in cartilage development and glucose metabolism during postnatal long bone growth.

Authors:  Tomoya Uchimura; Judith M Hollander; Daisy S Nakamura; Zhiyi Liu; Clifford J Rosen; Irene Georgakoudi; Li Zeng
Journal:  Development       Date:  2017-10-01       Impact factor: 6.868

Review 7.  Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome.

Authors:  Laura Bosch I Ara; Harshini Katugampola; Mehul T Dattani
Journal:  Front Pediatr       Date:  2021-02-02       Impact factor: 3.418

Review 8.  Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency.

Authors:  Michael B Ranke
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

Review 9.  Diagnosis of GH Deficiency Without GH Stimulation Tests.

Authors:  Anastasia Ibba; Sandro Loche
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-18       Impact factor: 5.555

Review 10.  Growth hormone therapy in short-stature patients with kyphoscoliosis: a literature review.

Authors:  Mariam S Alharbi
Journal:  EFORT Open Rev       Date:  2022-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.